Prenatal Hepatitis Panel
Also known as: PRENAT HEP
Use
Used for hepatitis B virus (HBV) and hepatitis C virus (HCV) prenatal screening. If the initial HCV antibody result is positive (low or high), the test reflexes to a quantitative nucleic acid amplification (NAAT) to confirm HCV infection. Similarly, if HBsAg screen is reactive (≥1.0), a confirmation is added. Not intended for blood donor screening or HCT/P screening. Clinically indicated for prenatal populations only. ([ltd.aruplab.com](https://ltd.aruplab.com/Tests/Pub/3006343?utm_source=openai))
Special Instructions
Not provided.
Limitations
Not to be used for blood donor screening, associated reentry protocols, or screening human cells, tissues, and cellular‑ and tissue‑based products (HCT/P). ([ltd.aruplab.com](https://ltd.aruplab.com/Tests/Pub/3006343?utm_source=openai))
New York Approved
Methodology
Immunoassay (ECLIA)
Biomarkers
LOINC Codes
- 13955-0 - HCV Ab SerPl Ql IA
- 48767-8 - Annotation comment Imp
- 57006-9 - HCV IgG Ser IA-aCnc
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
3 mL serum or plasma (Min: 2.5 mL)
Minimum Volume
2.5 mL
Container
Serum separator tube (SST); also acceptable: Lavender (EDTA) or pink (K2EDTA)
Collection Instructions
Separate from cells ASAP or within 2 hours of collection. Transfer to ARUP standard transport tube.
Causes for Rejection
Body fluids other than serum or plasma; heparinized plasma; specimens containing particulates or microbial contamination; heat‑inactivated, severely hemolyzed, or lipemic specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours after separation |
| Refrigerated | 6 days |
| Frozen | 2 months (avoid freeze/thaw cycles) |
Other tests from different labs that may be relevant